![Development of Novel, Value-Based, Digital Endpoints for Clinical Trials: A Structured Approach Toward Fit-for-Purpose Validation | Pharmacological Reviews Development of Novel, Value-Based, Digital Endpoints for Clinical Trials: A Structured Approach Toward Fit-for-Purpose Validation | Pharmacological Reviews](https://pharmrev.aspetjournals.org/sites/default/files/styles/medium/public/highwire/pharmrev/72/4.cover-source.jpg?itok=BvQ9KrmH)
Development of Novel, Value-Based, Digital Endpoints for Clinical Trials: A Structured Approach Toward Fit-for-Purpose Validation | Pharmacological Reviews
![Digital endpoints: Global opportunities and clinical, data protection and other challenges - MedCity News Digital endpoints: Global opportunities and clinical, data protection and other challenges - MedCity News](https://medcitynews.com/uploads/2017/08/GettyImages-510786414.jpg)
Digital endpoints: Global opportunities and clinical, data protection and other challenges - MedCity News
![Using Digital Health Technology to Better Generate Evidence and Deliver Evidence-Based Care - ScienceDirect Using Digital Health Technology to Better Generate Evidence and Deliver Evidence-Based Care - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109718344139-fx1.jpg)
Using Digital Health Technology to Better Generate Evidence and Deliver Evidence-Based Care - ScienceDirect
![Drugs in a Virtual World: The rise of digital health solutions in clinical trials · Bessemer Venture Partners Drugs in a Virtual World: The rise of digital health solutions in clinical trials · Bessemer Venture Partners](https://d33wubrfki0l68.cloudfront.net/4bc832db7cc828ed568a15e8860e4a93ab53d3e6/34c18/assets/media/covid19-impact-v2-.jpg)
Drugs in a Virtual World: The rise of digital health solutions in clinical trials · Bessemer Venture Partners
![The Rapid Evolution of Digital Endpoints: Are We Headed in the Right Direction? | by Jennifer Goldsack | Digital Medicine Society (DiMe) | Medium The Rapid Evolution of Digital Endpoints: Are We Headed in the Right Direction? | by Jennifer Goldsack | Digital Medicine Society (DiMe) | Medium](https://miro.medium.com/max/960/1*er7cS9PZmCO14FZf4nzxUQ.jpeg)
The Rapid Evolution of Digital Endpoints: Are We Headed in the Right Direction? | by Jennifer Goldsack | Digital Medicine Society (DiMe) | Medium
![Digital Progression Biomarkers as Novel Endpoints in Clinical Trials: A Multistakeholder Perspective - IOS Press Digital Progression Biomarkers as Novel Endpoints in Clinical Trials: A Multistakeholder Perspective - IOS Press](https://content.iospress.com/media/jpd/2021/11-s1/jpd-11-s1-jpd202428/jpd-11-jpd202428-g001.jpg?width=755)
Digital Progression Biomarkers as Novel Endpoints in Clinical Trials: A Multistakeholder Perspective - IOS Press
![The Rapid Evolution of Digital Endpoints: Are We Headed in the Right Direction? | by Jennifer Goldsack | Digital Medicine Society (DiMe) | Medium The Rapid Evolution of Digital Endpoints: Are We Headed in the Right Direction? | by Jennifer Goldsack | Digital Medicine Society (DiMe) | Medium](https://miro.medium.com/max/1400/1*P9F95_p4mAW8mMhjjnFF9Q.jpeg)
The Rapid Evolution of Digital Endpoints: Are We Headed in the Right Direction? | by Jennifer Goldsack | Digital Medicine Society (DiMe) | Medium
![PDF) Development of Novel, Value-Based, Digital Endpoints for Clinical Trials: A Structured Approach Toward Fit-for-Purpose Validation PDF) Development of Novel, Value-Based, Digital Endpoints for Clinical Trials: A Structured Approach Toward Fit-for-Purpose Validation](https://www.researchgate.net/profile/Frederik-Stuurman/publication/345336449/figure/tbl1/AS:1050102009458693@1627375237353/Potential-devices-and-candidate-digital-endpoints-for-use-in-clinical-trials-outside-of_Q320.jpg)